Search Results for "Montelukast Sodium Tablet Product Formulation"
Original Source: SINGULAIR [A-S Medication Solutions LLC]
SINGULAIR®(MONTELUKAST SODIUM) TABLETS, CHEWABLE TABLETS, AND ORAL GRANULES
Matching Channels
Singulair, the brand name for montelukast sodium, is produced by Merck & Co., Inc. Its annual sales in 2009 were $3m, ranking it 7th in the world. Singulair acts by blocking leukotrienes, to r...
Radioactive sodium iodine 131I radioiodine
Drug Delivery - news, views, blogs
Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals. Drug delivery technologies are patent protected formulat...
Laxatives are medicines that relieve constipation (difficulty with bowel movements). They are a popular type of over-the-counter remedy. They can also be prescribed for conditions that could get wor...
Matching News
Dr. Reddy's unveils montelukast sodium oral granules
Dr. Reddy's Laboratories has launched Montelukast Sodium Oral Granules, a bioequivalent generic version of Singulair (montelukast sodium) oral granules in the US market.
Dr Reddy's launches montelukast granules in the US
Dr Reddy's Laboratories has launched montelukast sodium oral granules 4mg, a generic version of Merck & Co's allergy and asthma drug Singulair, on the US market. The Indian company had last month laun...
Dr. Reddy's introduces generic Singulair oral granules in the U.S.
Dr. Reddy's Laboratories announced today that it has launched Montelukast Sodium Oral Granules, a bioequivalent generic version of Singulair (montelukast sodium) oral granules in the US market on Sept...
Qualitest confirms launch of generic Singulair Tablets for asthma and allergic rhinitis
Qualitest Pharmaceuticals today confirmed that it has launched a generic version of Singulair (montelukast sodium) Tablets and Chewable Tablets, following the expiration of the last patent that provid...
Mylan receives final FDA approval for Montelukast Sodium Tablets ANDA
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Mo...
Qualitest Launches Generic Singulair®
HUNTSVILLE, Ala., Aug. 6, 2012 /PRNewswire/ -- Qualitest Pharmaceuticals today confirmed that it has launched a generic version of Singulair (montelukast sodium) Tablets and Chewable Tablets,...
Type: Original PaperNovel self-microemulsifying floating tablets were developed to enhance the dissolution and oral absorption of the poorly water-soluble tetrahydrocurcumin (THC). Their physicochemic...
Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Montelukast Sodium Tablets (10 mg) and Montelukast Sodium Chewable Tablets (4 mg & 5 mg), bioequiva...
Matching PubMed Articles
Incompatibility of croscarmellose sodium with alkaline excipients in a tablet formulation.
Abstract The objective of the current work was to study an observed incompatibility between croscarmellose sodium and basic excipients in a tablet formulation. Significant dissolution slowdown was obs...
Purpose: To evaluate and optimize sodium lauryl sulfate (SLS) and magnesium stearate (Mg.St) levels, with respect to dissolution and compaction, in a high dose, poorly soluble drug tablet formulation....
Design and evaluation of a new formulation of enalapril maleate tablet.
Enalapril maleate, one of the Angiotensin converting enzyme (ACE) inhibitor is effective in the treatment of hypertension. Enalapril maleate is selected for the present study. The aim of this study wa...
Enhanced Bioavailability of Atorvastatin Calcium from Stabilized Gastric Resident Formulation.
Oral bioavailability of atorvastatin calcium (ATC) is very low (only 14%) due to instability and incomplete intestinal absorption and/or extensive gut wall extraction. When ATC is packed in the form o...
PURPOSE: To compare the bioavailability (BA) and pharmacokinetic (PK) properties and to demonstrate the bioequivalence (BE) between two active product ingredient (API) sources of eslicarbazepine aceta...